Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab - Concepedia

Concepedia

Publication | Open Access

Systemic immune‐inflammation index, neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio can predict clinical outcomes in patients with metastatic non‐small‐cell lung cancer treated with nivolumab

DOI Full Paper Access

357

Citations

36

References

2019

Year

Jingjing Liu, Shuang Li, Shuang Zhang, Ying Liu, Lixia Ma, Jing Zhu, Ying Xin, Ying Wang, Changliang Yang, Ying Cheng

Journal of Clinical Laboratory Analysis

Abstract

The SII, NLR, and PLR are promising prognostic predictor for patients with metastatic NSCLC patients.

References

	Year	Citations

Page 1